Clinical Trials in Georgia

Showing 1181-1200 of 16,324 trials

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

NCT06056011

The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.

Febrile Illness

Baxter Healthcare Corporation373 participantsStarted Feb 2024

Fayetteville, Georgia, United States • Mankato, Minnesota, United States • Buffalo, New York, United States +2 more locations

RECRUITING55 miles

Prospective Study to Assess a Diagnostic Aid for Cancer

NCT07046260

The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.

Cancer

Harbinger Health1,650 participantsStarted Jul 2025

Coronado, California, United States • Poway, California, United States • San Diego, California, United States +36 more locations

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

Prospective Study to Assess a Diagnostic Aid for Cancer

Find Trials by Condition in Georgia

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Connect for Cancer Prevention Study (Connect)

Type 1 Diabetes Extension Study

AMPLATZER PFO Occluder Post Approval Study

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Secukinumab Open Label Roll-over Extension Protocol

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening